New York State Common Retirement Fund’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Sell
33,982
-177,158
-84% -$5.24M ﹤0.01% 1721
2026
Q1
$6.37M Hold
211,140
0.01% 919
2025
Q4
$7.33M Hold
211,140
0.01% 878
2025
Q3
$7.67M Buy
211,140
+8,334
+4% +$283K 0.01% 868
2025
Q2
$6.36M Hold
202,806
0.01% 970
2025
Q1
$6.02M Hold
202,806
0.01% 965
2024
Q4
$5.98M Hold
202,806
0.01% 1031
2024
Q3
$6.31M Sell
202,806
-29,788
-13% -$1.08M 0.01% 1000
2024
Q2
$7.88M Sell
232,594
-15,874
-6% -$810K 0.01% 919
2024
Q1
$16.2M Buy
248,468
+4,029
+2% +$276K 0.02% 618
2023
Q4
$16.7M Buy
244,439
+45,798
+23% +$2.38M 0.02% 608
2023
Q3
$10.3M Buy
198,641
+46,902
+31% +$2.78M 0.01% 796
2023
Q2
$9.1M Buy
151,739
+149,754
+7,544% +$8.55M 0.01% 933
2023
Q1
$98.1K Buy
+1,985
New +$112K ﹤0.01% 2821

Other funds holding IMCR

New York State Common Retirement Fund's IMCR Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Immunocore (IMCR) stake by 84% in Q2 2026, selling an estimated $5.24M and leaving 33,982 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

New York State Common Retirement Fund first reported a position in IMCR in Q1 2023 and has held it in 14 quarters since. The position peaked at $16.7M in Q4 2023. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • New York State Common Retirement Fund held 33,982 shares of Immunocore worth $1.08M as of Q2 2026.
  • New York State Common Retirement Fund sold 177,158 Immunocore shares in Q2 2026, an estimated $5.24M.
  • Immunocore made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1721 holding.
  • New York State Common Retirement Fund first reported a position in Immunocore in Q1 2023 and has held it in 14 quarters since.
  • New York State Common Retirement Fund's Immunocore position peaked at $16.7M in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.